share_log

HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $4 Price Target

HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $4 Price Target

HC Wainwright & Co.重申买入 Context Therapeutics,维持4美元的目标价格
Benzinga Real-time News ·  2023/02/07 06:21

HC Wainwright & Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:CNTX) with a Buy and maintains $4 price target.

HC Wainwright & Co. 分析师艾米丽·博德纳尔重申Context Therapeutics(纳斯达克股票代码:CNTX)的买入,并维持4美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发